Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

A Lean Quality Improvement Initiative to Enhance Tobacco Use Treatment in a Cancer Hospital.

Meyer C, Mitra S, Ruebush E, Sisler L, Wang K, Goldstein AO.

Int J Environ Res Public Health. 2020 Mar 24;17(6). pii: E2165. doi: 10.3390/ijerph17062165.

2.

Using a Family Systems Approach to Treat Tobacco Use among Cancer Patients.

Ruebush E, Mitra S, Meyer C, Sisler L, Goldstein AO.

Int J Environ Res Public Health. 2020 Mar 19;17(6). pii: E2050. doi: 10.3390/ijerph17062050.

3.

Risk, Resilience, and Smoking in a National, Probability Sample of Sexual and Gender Minority Adults, 2017, USA.

Lee JGL, Shook-Sa BE, Gilbert J, Ranney LM, Goldstein AO, Boynton MH.

Health Educ Behav. 2020 Apr;47(2):272-283. doi: 10.1177/1090198119893374. Epub 2020 Jan 29.

PMID:
31994418
4.

Youth source of acquisition for E-Cigarettes.

Baker HM, Kowitt SD, Meernik C, Heck C, Martin J, Goldstein AO, Ranney L.

Prev Med Rep. 2019 Oct 25;16:101011. doi: 10.1016/j.pmedr.2019.101011. eCollection 2019 Dec.

5.

Vaping industry-funded academic scholarships.

Baler G, Paci K, Kowitt SD, Goldstein AO.

Tob Control. 2019 Dec 26. pii: tobaccocontrol-2019-055158. doi: 10.1136/tobaccocontrol-2019-055158. [Epub ahead of print] No abstract available.

PMID:
31879374
6.

Electronic Cigarettes: More Questions Than Answers.

Baca-Atlas M, Mounsey A, Goldstein AO.

Am Fam Physician. 2019 Nov 15;100(10):600-601. No abstract available.

PMID:
31730322
7.

An Eye Tracking Study of Anti-Smoking Messages on Toxic Chemicals in Cigarettes.

Ranney LM, Kowitt SD, Queen TL, Jarman KL, Goldstein AO.

Int J Environ Res Public Health. 2019 Nov 12;16(22). pii: E4435. doi: 10.3390/ijerph16224435.

8.

Impact of non-menthol flavours in e-cigarettes on perceptions and use: an updated systematic review.

Meernik C, Baker HM, Kowitt SD, Ranney LM, Goldstein AO.

BMJ Open. 2019 Oct 16;9(10):e031598. doi: 10.1136/bmjopen-2019-031598.

9.

Willingness-to-try various tobacco cessation methods among US adult cigarette smokers.

Enyioha C, Meernik C, Ranney L, Goldstein AO, Sellman K, Kistler CE.

Tob Prev Cessat. 2019 May;5. pii: 18. doi: 10.18332/tpc/108555. No abstract available.

10.

Risk factors for multiple tobacco product use among high school youth.

Osman A, Kowitt SD, Ranney LM, Heck C, Goldstein AO.

Addict Behav. 2019 Dec;99:106068. doi: 10.1016/j.addbeh.2019.106068. Epub 2019 Jul 30.

PMID:
31470239
11.

Smoking Cessation and Low-Dose Computed Tomography Screening: A Necessary Pair.

Warren GW, Wang K, Goldstein AO.

J Thorac Oncol. 2019 Sep;14(9):1495-1497. doi: 10.1016/j.jtho.2019.05.038. No abstract available.

PMID:
31445726
12.

Product attributes important to US adult consumers' use of electronic nicotine delivery systems: a discrete choice experiment.

Kistler CE, Ranney LM, Sutfin EL, Chrzan K, Wretman CJ, Enyioha C, Meernik C, Berman M, Zarkin GA, Goldstein AO.

BMJ Open. 2019 Aug 15;9(8):e027247. doi: 10.1136/bmjopen-2018-027247.

13.

Do Smokers Recall Source or Quitline on Cigarette Constituent Messages?

Jarman KL, Kowitt SD, Queen TL, Ranney LM, Kim K, Jones EE, Donovan E, Goldstein AO.

Tob Regul Sci. 2018 Nov;4(6):66-82. doi: 10.18001/TRS.4.6.7.

14.

Asking the right questions about secondhand smoke.

Klein JD, Chamberlin ME, Kress EA, Geraci MW, Rosenblatt S, Boykan R, Jenssen B, Rosenblatt SM, Milberger S, Adams WG, Goldstein AO, Rigotti NA, Hovell MF, Holm AL, Vandivier RW, Croxton TL, Young PL, Blissard L, Jewell K, Richardson L, Ostrow J, Resnick EA.

Nicotine Tob Res. 2019 Aug 13. pii: ntz125. doi: 10.1093/ntr/ntz125. [Epub ahead of print]

PMID:
31407779
15.

Receipt of direct tobacco mail/email coupons and coupon redemption: Demographic and socioeconomic disparities among adult smokers in the United States.

Osman A, Queen T, Choi K, Goldstein AO.

Prev Med. 2019 Sep;126:105778. doi: 10.1016/j.ypmed.2019.105778. Epub 2019 Jul 16.

PMID:
31323282
16.

Vaping cannabis among adolescents: prevalence and associations with tobacco use from a cross-sectional study in the USA.

Kowitt SD, Osman A, Meernik C, Zarkin GA, Ranney LM, Martin J, Heck C, Goldstein AO.

BMJ Open. 2019 Jun 13;9(6):e028535. doi: 10.1136/bmjopen-2018-028535.

17.

Adolescents' first tobacco products: Associations with current multiple tobacco product use.

Kowitt SD, Goldstein AO, Sutfin EL, Osman A, Meernik C, Heck C, Ranney LM.

PLoS One. 2019 May 23;14(5):e0217244. doi: 10.1371/journal.pone.0217244. eCollection 2019.

18.

Changes in Physician Knowledge, Attitudes, Beliefs, and Practices regarding Lung Cancer Screening.

Henderson LM, Benefield TS, Bearden SC, Reuland DS, Brenner AT, Goldstein AO, Throneburg A, Rivera MP.

Ann Am Thorac Soc. 2019 Aug;16(8):1065-1069. doi: 10.1513/AnnalsATS.201812-867RL. No abstract available.

PMID:
31075047
19.

Opinions and Practices of Lung Cancer Screening by Physician Specialty.

Henderson LM, Marsh MW, Benefield TS, Jones LM, Reuland DS, Brenner AT, Goldstein AO, Molina PL, Maygarden SJ, Rivera MP.

N C Med J. 2019 Jan-Feb;80(1):19-26. doi: 10.18043/ncm.80.1.19.

20.

Adolescents' Aided Recall of Targeted and Non-Targeted Tobacco Communication Campaigns in the United States.

Kowitt SD, Lazard AJ, Queen TL, Noar SM, Goldstein AO.

Int J Environ Res Public Health. 2018 Oct 25;15(11). pii: E2363. doi: 10.3390/ijerph15112363.

21.

Trends and Racial Disparities in Mono, Dual, and Poly Use of Tobacco Products Among Youth.

Osman A, Kowitt SD, Ranney LM, Heck C, Goldstein AO.

Nicotine Tob Res. 2018 Aug 14;20(suppl_1):S22-S30. doi: 10.1093/ntr/nty051.

22.

A Narrative Review of Intensive Group Tobacco Treatment: Clinical, Research, and US Policy Recommendations.

Kotsen C, Santorelli ML, Bloom EL, Goldstein AO, Ripley-Moffitt C, Steinberg MB, Burke MV, Foulds J.

Nicotine Tob Res. 2019 Nov 19;21(12):1580-1589. doi: 10.1093/ntr/nty162.

PMID:
30124924
23.

Billing Practices Among US Tobacco Use Treatment Providers.

Bloom EL, Burke MV, Kotsen C, Goldstein AO, Ripley-Moffitt C, Steinberg MB, Dailey M, Hunt LE, Bars MP.

J Addict Med. 2018 Sep/Oct;12(5):381-386. doi: 10.1097/ADM.0000000000000423.

PMID:
30044243
24.

Examining Patient Perspectives on Weight Management Support in the Primary Care Setting.

Bloom K, Adler J, Bridges C, Bernstein J, Rini C, Goldstein AO, Ripley-Moffitt C.

J Prim Prev. 2018 Aug;39(4):387-399. doi: 10.1007/s10935-018-0516-9.

PMID:
30008041
25.

Treating Tobacco Use in Patients with Incurable Malignancies: Should We Even Start the Conversation?

Trout S, Goldstein AO, Marks L, Ripley-Moffitt C.

J Palliat Med. 2018 Jun;21(6):746-750. doi: 10.1089/jpm.2017.0304. Epub 2018 May 7.

26.

The effect of cigarillo packaging elements on young adult perceptions of product flavor, taste, smell, and appeal.

Meernik C, Ranney LM, Lazard AJ, Kim K, Queen TL, Avishai A, Boynton MH, Sheeran PJ, Goldstein AO.

PLoS One. 2018 Apr 19;13(4):e0196236. doi: 10.1371/journal.pone.0196236. eCollection 2018.

27.

Information to Improve Public Perceptions of the Food and Drug Administration (FDA's) Tobacco Regulatory Role.

Osman A, Kowitt SD, Sheeran P, Jarman KL, Ranney LM, Goldstein AO.

Int J Environ Res Public Health. 2018 Apr 14;15(4). pii: E753. doi: 10.3390/ijerph15040753.

28.

Attitudes Toward FDA Regulation of Newly Deemed Tobacco Products.

Kowitt SD, Goldstein AO, Schmidt AM, Hall MG, Brewer NT.

Tob Regul Sci. 2017 Oct;3(4):504-515. doi: 10.18001/TRS.3.4.10. Epub 2017 Oct 1.

29.

Opinions, practice patterns, and perceived barriers to lung cancer screening among attending and resident primary care physicians.

Henderson LM, Jones LM, Marsh MW, Brenner AT, Goldstein AO, Benefield TS, Greenwood-Hickman MA, Molina PL, Rivera MP, Reuland DS.

Risk Manag Healthc Policy. 2018 Jan 22;10:189-195. doi: 10.2147/RMHP.S143152. eCollection 2017.

30.

Factors Influencing Trust in Agencies That Disseminate Tobacco Prevention Information.

Ranney LM, Jarman KL, Baker HM, Vu M, Noar SM, Goldstein AO.

J Prim Prev. 2018 Apr;39(2):99-116. doi: 10.1007/s10935-018-0501-3.

31.

E-Cigarette Use Among Adolescents Not Susceptible to Using Cigarettes.

Kowitt SD, Osman A, Ranney LM, Heck C, Goldstein AO.

Prev Chronic Dis. 2018 Feb 1;15:E18. doi: 10.5888/pcd15.170368.

32.

Continuing Medical Education and Firearm Violence Counseling.

Damari ND, Ahluwalia KS, Viera AJ, Goldstein AO.

AMA J Ethics. 2018 Jan 1;20(1):56-68. doi: 10.1001/journalofethics.2018.20.1.stas1-1801.

33.

Attitudes towards Potential New Tobacco Control Regulations among U.S. Adults.

Schmidt AM, Kowitt SD, Myers AE, Goldstein AO.

Int J Environ Res Public Health. 2018 Jan 5;15(1). pii: E72. doi: 10.3390/ijerph15010072.

34.

Perceptions of Tobacco Control Media Campaigns Among Smokers With Lower Socioeconomic Status.

McCullough A, Meernik C, Baker H, Jarman K, Walsh B, Goldstein AO.

Health Promot Pract. 2018 Jul;19(4):550-559. doi: 10.1177/1524839917741485. Epub 2017 Nov 30.

PMID:
29190143
35.

Using Lean Quality Improvement Tools to Increase Delivery of Evidence-Based Tobacco Use Treatment in Hospitalized Neurosurgical Patients.

Sisler L, Omofoye O, Paci K, Hadar E, Goldstein AO, Ripley-Moffitt C.

Jt Comm J Qual Patient Saf. 2017 Dec;43(12):633-641. doi: 10.1016/j.jcjq.2017.06.012.

PMID:
29173283
36.

Should the Legal Age for Tobacco Be Raised? Results From a National Sample of Adolescents.

Kowitt SD, Schmidt AM, Myers AE, Goldstein AO.

Prev Chronic Dis. 2017 Nov 16;14:E112. doi: 10.5888/pcd14.170255.

37.

Use of Expired Air Carbon Monoxide Testing in Clinical Tobacco TreatmentĀ Settings.

Goldstein AO, Gans SP, Ripley-Moffitt C, Kotsen C, Bars M.

Chest. 2018 Feb;153(2):554-562. doi: 10.1016/j.chest.2017.11.002. Epub 2017 Nov 11. Review.

PMID:
29137909
38.

Are Some of the Cigar Warnings Mandated in the U.S. More Believable Than Others?

Jarman KL, Kowitt SD, Cornacchione Ross J, Goldstein AO.

Int J Environ Res Public Health. 2017 Nov 10;14(11). pii: E1370. doi: 10.3390/ijerph14111370.

39.

Provider satisfaction with an inpatient tobacco treatment program: results from an inpatient provider survey.

Trout S, Ripley-Moffitt C, Meernik C, Greyber J, Goldstein AO.

Int J Gen Med. 2017 Oct 19;10:363-369. doi: 10.2147/IJGM.S136965. eCollection 2017.

40.

Public Knowledge and Credibility Perceptions of the FDA as a Tobacco Regulator.

Schmidt AM, Jarman KL, Ranney LM, Queen TL, Noar SM, Ruel L, Agans R, Hannan A, Goldstein AO.

Nicotine Tob Res. 2018 Sep 25;20(11):1310-1316. doi: 10.1093/ntr/ntx215.

41.

Cigarette Constituent Health Communications for Smokers: Impact of Chemical, Imagery, and Source.

Kowitt SD, Sheeran P, Jarman KL, Ranney LM, Schmidt AM, Noar SM, Huang LL, Goldstein AO.

Nicotine Tob Res. 2019 May 21;21(6):841-845. doi: 10.1093/ntr/ntx226.

42.

Believability of Cigarette Warnings About Addiction: National Experiments of Adolescents and Adults.

Lazard AJ, Kowitt SD, Huang LL, Noar SM, Jarman KL, Goldstein AO.

Nicotine Tob Res. 2018 Jun 7;20(7):867-875. doi: 10.1093/ntr/ntx185.

43.

Perceptions of the Food and Drug Administration as a Tobacco Regulator.

Jarman KL, Ranney LM, Baker HM, Vallejos QM, Goldstein AO.

Tob Regul Sci. 2017 Apr;3(2):239-247. doi: 10.18001/TRS.3.2.12. Epub 2017 Apr 1.

44.

Erratum to: understanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: a national phone survey of U.S. adults, 2014-2015.

Boynton MH, Agans RP, Michael Bowling J, Brewer NT, Sutfin EL, Goldstein AO, Noar SM, Ribisl KM.

BMC Public Health. 2017 Sep 20;17(1):726. doi: 10.1186/s12889-017-4760-3. No abstract available.

45.

Evaluation of Community-Based Cessation Programs: How Do Smokers with Behavioral Health Conditions Fare?

Meernik C, McCullough A, Ranney L, Walsh B, Goldstein AO.

Community Ment Health J. 2018 Feb;54(2):158-165. doi: 10.1007/s10597-017-0155-2. Epub 2017 Aug 2.

PMID:
28770359
46.

Development of the FDA Tobacco Credibility Scale (FDA-TCS).

Schmidt AM, Ranney LM, Noar SM, Goldstein AO.

Tob Regul Sci. 2017 Jan;3(1):47-55. doi: 10.18001/TRS.3.1.5.

47.

Consumers' Preferences for Electronic Nicotine Delivery System Product Features: A Structured Content Analysis.

Kistler CE, Crutchfield TM, Sutfin EL, Ranney LM, Berman ML, Zarkin GA, Goldstein AO.

Int J Environ Res Public Health. 2017 Jun 7;14(6). pii: E613. doi: 10.3390/ijerph14060613.

48.

Trends and Correlates of Hookah Use Among High School Students in North Carolina.

Huang LL, Sutfin EL, Kowitt S, Patel T, Ranney L, Goldstein AO.

N C Med J. 2017 May-Jun;78(3):149-155. doi: 10.18043/ncm.78.3.149.

49.

Awareness and trust of the FDA and CDC: Results from a national sample of US adults and adolescents.

Kowitt SD, Schmidt AM, Hannan A, Goldstein AO.

PLoS One. 2017 May 16;12(5):e0177546. doi: 10.1371/journal.pone.0177546. eCollection 2017.

50.

Providing Nicotine Replacement Therapy in Focus Groups.

Jones EE, Jarman KL, Goldstein AO.

Nicotine Tob Res. 2018 Feb 7;20(3):399-400. doi: 10.1093/ntr/ntx090. No abstract available.

Supplemental Content

Loading ...
Support Center